Microsoft Corp. announced that PURE Bioscience has selected Microsoft Dynamics AX 4.0 to speed and integrate its business processes, helping to support the company’s compliance with the Sarbanes-Oxley Act and with the requirements of numerous regulatory authorities, including the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) in the United States. Microsoft Dynamics AX is a comprehensive business-management solution for midsize and larger organizations that offers a high degree of scalability, customizability and full industry-specific functionality. It helps optimize and centralize supply chain processes and improves real-time visibility into operations.
PURE Bioscience, headquartered in El Cajon, Calif., develops and markets technology-based bioscience products that provide nontoxic solutions to numerous global health challenges. As a public company, PURE needed to remain compliant with Section 404 of the Sarbanes-Oxley Act. It also sought a way to produce its financials more rapidly because its growth would move the company into the category of an accelerated Securities and Exchange Commission (SEC) filer during 2008.
Microsoft, Microsoft Dynamics, Bioscience, Press